What does BRIDGE mean in BRITISH MEDICINE

BETA stands for Beta Radiation Investigation With Direct Stenting and Galileo in Europe. It is a clinical trial launched to investigate the safety and efficacy of direct stenting with a temperature-sensitive polymer-coated beta radiation-emitting stent, in combination with intracoronary imaging using the Galileo system, in patients with symptomatic coronary artery disease in Europe.

The Galileo System involves real-time imaging of plaque morphology during complex percutaneous coronary intervention (PCI) procedures such as direct stenting. This helps doctors better understand how best to treat patients suffering from severe forms of heart disease.

The primary objectives of BETA are to assess the safety of direct stenting using a temperature-sensitive polymer-coated beta radiation emitting stent combined with intracoronary imaging using the Galileo system; and also measure its effectiveness on cardiac outcomes at three months follow-up compared to conventional balloon angioplasty alone for treating symptomatic coronary artery disease in Europe.

Patients who might benefit from BETA include those suffering from symptomatic coronary artery disease who may not respond well to conventional treatments such as balloon angioplasty alone. The treatment offers more precise treatment options that help doctors target specific areas where fatty deposits have built up inside arteries, thereby reducing heart attack risk while improving overall health outcomes.

The Beta Radiation Investigation With Direct Stenting and Galileo in Europe clinical trial is expected to run for two years, after which its results will be evaluated.